-
UPDATE: Morgan Keegan Downgrades Home Properties to Market Perform
Wednesday, January 4, 2012 - 12:55pm | 96Morgan Keegan has downgraded Home Properties (NYSE: HME) from Outperform to Market Perform and has lowered the price target from $65 to $60 in a research report out today. In the report, Morgan Keegan states, "We are downgrading HME shares from an Outperform to a Market Perform rating, reflecting...
-
UPDATE: Morgan Keegan Downgrades AvalonBay Communities to Market Perform
Wednesday, January 4, 2012 - 12:49pm | 81Morgan Keegan has downgraded AvalonBay Communities (NYSE: AVB) from Outperform to Market Perform and has lowered the price target from $150 to $135 in a research report out today. In the report, Morgan Keenan states, "We are downgrading AVB shares from an Outperform to a Market Perform rating,...
-
Morgan Keenan Upgrades Edwards Lifesciences from Market Perform to Outperform
Monday, July 25, 2011 - 8:42am -
Morgan Keenan Intiates Coverage on Iridium Communications With PT of $12 and Rating of Outperform
Thursday, July 21, 2011 - 9:12am -
Morgan Keenan Comments on AtriCure
Monday, July 18, 2011 - 8:36am | 105Morgan Keegan has published a report on AtriCure (NASDAQ: ATRC) after a grant to develop minimally invasive surgical technology. In the report, Morgan Keenan comments, "We think AtriCure shares are currently traded near fair value. Using a 10-year DCF and EV/Sales, AtriCure shares appear fairly...